Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Equity (2016 - 2026)

Nutex Health (NUTX) has disclosed Return on Equity for 14 consecutive years, with 0.44% as the latest value for Q1 2026.

  • For Q1 2026, Return on Equity fell 22.0% year-over-year to 0.44%; the TTM value through Mar 2026 reached 0.44%, down 22.0%, while the annual FY2025 figure was 0.59%, 12.0% down from the prior year.
  • Return on Equity hit 0.44% in Q1 2026 for Nutex Health, up from 0.42% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.71% in Q4 2024 and bottomed at 4.08% in Q2 2023.
  • Average Return on Equity over 5 years is 0.66%, with a median of 0.25% recorded in 2023.
  • Year-over-year, Return on Equity plummeted -417bps in 2023 and then skyrocketed 372bps in 2024.
  • Nutex Health's Return on Equity stood at 3.42% in 2022, then surged by 86bps to 0.47% in 2023, then soared by 251bps to 0.71% in 2024, then plummeted by -41bps to 0.42% in 2025, then grew by 6bps to 0.44% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.44%, 0.42%, and 0.68% for Q1 2026, Q4 2025, and Q3 2025 respectively.